Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection.
OBJECTIVE
To review post implant morbidity in patients with prior transurethral prostate resection (TURP).


METHODS
Nineteen patients with stage T1-T2 prostatic carcinoma and prior TURP were treated with I-125 or Pd-103 implantation from 1991 through 1994. Follow-up ranged from 1 to 6 years (median: 3 years). The time from TURP to implantation ranged from 2 months to 15 years (median: 3 years).


RESULTS
Only one patient developed mild urinary stress incontinence, 6 months following his I-125 implant. The actuarial freedom from permanent urinary incontinence at 3 years after implantation was 94%. No patient required urethral dilatation for urethral stricture. Eleven patients were sexually potent prior to implantation. At 3 years after treatment, all patients had maintained potency.


CONCLUSIONS
In our experience, there has been remarkably little adverse sequelae following I-125 or Pd-103 implantation in patients with a prior history of TURP.
Wallner
K
K
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Lee
H
H
Wasserman
S
S
Dattoli
M
M
D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000009:adverse effects*; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010165:Palladium / Q000009:adverse effects; D010410:Penile Erection; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D011868:Radioisotopes / Q000009:adverse effects; D012007:Rectum / Q000528:radiation effects; D014549:Urinary Incontinence / Q000209:etiology*
D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium